The Hopkins Club for Innovation and Entrepreneurship

2020 Hopkins Salon VI: Where Exactly Are We with Vaccines and Treatments for COVID-19?
2020-05-02 00:00 (America/New_York)
With confirmed COVID-19 cases continuing to grow, scientists are pushing forward with efforts to find cures. This talk features its summary

About this Event

Helen F. Schiltz, PhD.
Senior Director of Research and Development at Sabin Vaccine Institute
Background:
With confirmed COVID-19 cases approaching 3 million worldwide, 1 million of them in the states, and continuing to grow, scientists are pushing forward with efforts to develop vaccines and treatments to slow the pandemic and lessen the disease’s damage. Potential candidates include antiviral drugs, some of which are already in use against other illnesses, vaccines that could be used as a preventive measure against the disease, and more. This talk features the status quo for the most recent developments in COVID-19 therapeutics.
Agenda:

7:45pm, Online registration starts
8-8:45pm, Speech by Dr Schiltz
8:45-9pm, Q&A

About the speaker:
Dr. Schiltz Is currently the senior director of R and D at the Sabin Vaccine Institute. She has over 25 years of research and development and program management experience from biotech industry and US government. She spent more than 10 years in molecular diagnostic industry for technology and product development to support cancer and infectious disease diagnostics.
Prior to Sabin Vaccine Institute, she was a program officer in the Office of Biodefense, Research Resources, and Translational Research (OBRRTR) of Division of Microbiology and Infectious Diseases (DMID), the National Institute of Allergy and Infectious Diseases (NIAID). She helped to establish the centralized biodefense reagent resources contract of $140 million, BEI Resources, a gateway to select agents and reagents that are essential for many researchers working in the biodefense and emerging infections arena. She then became a program officer in the Drug Development Section (DDS) and served as the Acting Section Chief in 2009. In her roles throughout the years in DDS, Dr. Schiltz has been instrumental in developing and implementing NIAID’s therapeutic portfolio, with over 20 novel antiviral and antibiotic development programs and over $800 million of total investment. She has advanced several antiviral programs into Phase 1 and 2 clinical trials and one program for NDA enabling development, including small molecule drugs and biologics for viral infection (such as smallpox, Dengue, influenza, Ebola, Marburg, and Yellow Fever, West Nile virus infection, and COVID-19), and novel antibiotics against multi-drug resistant Gram negative and Gram-positive bacteria.
In addition, Dr. Schiltz had served as the NIAID’s subject matter expert and representative on numerous US government interagency working groups for antiviral product pipeline and development strategy.

About Sabin Vaccine Institute
Sabin Vaccine Institute (Sabin), located in Washington, D.C., is a nonprofit (501(c)(3)) organization promoting global vaccine development, availability, and use. Through its work, Sabin hopes to reduce human suffering by preventing the spread of vaccine-preventable, communicable disease in humans through herd immunity, and also hopes to mitigate the poverty caused by these diseases.
The Sabin Vaccine Institute is a leading advocate for expanding vaccine access and uptake globally, advancing vaccine research and development, and amplifying vaccine knowledge and innovation.
Read More at https://www.sabin.org/

2020 Hopkins Salon V COVID-19: The response of the world's top trauma center
2020-04-18 00:00 (America/New_York)
2020 Hopkins Salon IV
Speaker: Dr. Fumin Hu, Chief Technology Officer, Shock Trauma Center, University of Maryland
8:00 p.m. Saturday, April 18, Eastern Time
(Beijing time, April 19th, 8 a.m.)
Online activities, non-members can also participate
Background: How does the United States prevent epidemics?
In 2019, the new coronavirus (COVID-19) is spreading globally, and the number of infected people is approaching 2 million. According to the CDC weekly report, the current epidemic in Washington DC and Maryland continues to rise.
Recently, Maryland Governor Larry Hogan announced the reconstruction of the Baltimore Convention Center as a square cabin hospital, becoming a federal medical station in response to the COVID-19 pandemic. The Federal Medical Station operates under the joint guidance of the University of Maryland Medical System and Johns Hopkins Hospital.

Maryland Governor Larry Hogan announces conversion of Baltimore Convention Center to COVID-19 Square Cabin Hospital | ABC News

Maryland Emergency Center helicopter team rescues patients | MIEMS
The R Adams Cowley Shock Trauma Center at the University of Maryland Medical Center is the world’s first fully integrated trauma center, and is still the center of trauma research, patient care, and teaching at home and abroad. The Maryland Shock Trauma Center is the birthplace of the “golden hour” trauma concept and the birthplace of many life-saving practices in modern trauma medicine. The Shock Trauma Center is also at the heart of Maryland’s unparalleled emergency medical services system

Maryland Trauma Center Medical Team Participates in Wenchuan Earthquake Relief | West China Medical University Related Website
In this salon, the Hopkins Salon focuses on the epidemic prevention situation in the United States, and specially invites the world ’s first trauma hospital, the Chief Technology Officer of the University of Maryland Shock Trauma Center, and the professor of medical school Dr. Hu Fumin to analyze the US epidemic situation and share the first-line ICU trauma experience The content includes: 1) Maryland and the United States emergency medical system; 2) the current emergency system response to COVID-19 epidemic prevention. It is worth noting that the University of Maryland Shock Trauma Center is also actively involved in global trauma relief operations. During the Wenchuan Earthquake, Dr. Hu was one of the most important members of the American medical team. He and his colleagues worked with the team at West China Hospital to treat more than 100 critically ill patients. Dr. Hu will also share examples of the first aid of the Wenchuan earthquake and the moving stories behind it.
Hopkins Salon 2020 V

Topic: Analyze the epidemic situation in the United States and share first-line trauma first aid experience
Speaker: Dr. Fumin Hu | University of Maryland School of Medicine / Shock Trauma Center
Time: April 18th, 8-9: 30pm EDT
Location: Live online

Guest

Dr. Hu Fumin Associate Professor, University of Maryland School of Medicine Chief Technology Officer, Shock Trauma Center, Maryland Associate Professor of Anesthesiology, Surgery, and Epidemiology, University of Maryland School of Medicine (UMB), Chief Technology Officer, Shock Trauma Center, Maryland, and Adjunct Associate Professor, Department of Computer Science and Electrical Engineering, UMBC The University of Maryland, Baltimore, Shock Trauma Center (STC) and the National Trauma and EMS National Research Center have more than 25 years of clinical research experience.
Dr. Hu ’s group was funded by NSF to study the “support information and rapid transfer of responsibility” in the ICU; it was also funded by the US Army and Air Force to collect vital signs data from hospitals and pre-traumatic centers, and analyzed Vital signs are associated with specific interventions and outcomes. Dr. Hu has developed and operated a real-time vital signs data collection and display system at STC. In the past 25 years, Dr. Hu has served by NSF, UA Army, U.S. Air Force, Naval Research Office (ONR), NASA, NLM / NIH, Medical Research and Quality Agency (AHRQ), in similar technology development and testing areas Provide funding. He has more than 100 peer-reviewed publications in real-time data processing, trauma care, human factors, ergonomics, and usability (especially in emergency situations and trauma care). In the past 5 years, he has completed 12 grants / contracts (> 10 million USD) funded by the US Department of Defense.
Currently, Dr. Hu is the PI or Co-PI of five US Department of Defense (DoD) -funded projects (over US $ 6 million) related to using continuous trauma patient vital signs to predict short-term and long-term patient outcomes. He is also a member of the editorial board of intensive care medicine and participated in the organization of three Sino-American trauma and disaster medical conferences. After the Wenchuan earthquake, at the invitation of Mr. Zhou Wenzhong, Chinese Ambassador to the United States, he and four colleagues from the University of Maryland Shock Trauma Center went to Chengdu to form an intensive care team with Chinese trauma emergency experts to jointly treat more than 100 trauma patients.
Host

Dr. Fenghao Chen / AI Medical Hopkins Innovation and Entrepreneurship Club Chairman LINKSciences / CEO
Dr. Johns Hopkins University, former research director of BGI Gene Americas Research Institute, founder of medical artificial intelligence company LINKSciences. The LINKMedicine subdivision disease expertise analysis platform, which has leading algorithms and independent intellectual property rights, covers 5000 hospitals across the United States, more than 70,000 subdivision diseases, and finds the best consultation path from hundreds of millions of programs It is a gold standard for the evaluation of a new generation of hospitals driven by data. Hop Huafeng | Chairman of the Hopkins Innovation and Entrepreneurship Club, Dr. Fenghao Chen in Innovation / AI Healthcare Hopkins Innovation and Entrepreneurship Club Chairman LINKSciences / CEO Dr. Johns Hopkins University, former research director of BGI Gene Americas Research Institute, founder of medical artificial intelligence company LINKSciences. The LINKMedicine subdivision disease expertise analysis platform, which has leading algorithms and independent intellectual property rights, covers 5000 hospitals across the United States, more than 70,000 subdivision diseases, and finds the best consultation path from hundreds of millions of programs It is a gold standard for the evaluation of a new generation of hospitals driven by data. Hope Huafeng | Chairman of the Hopkins Innovation and Entrepreneurship Club and head of the Innovation Center.
7: 45-8: 00pm online check-in, guest exchange 8: 00-9: 00pm Keynote Speech: Current US Epidemic Situation-Dr. Hu Fumin 9: 00-9: 15pm Questions and answers from the audience / Q & A 9: 15-9: 30pm Briefing of Hope China Epidemic Prevention Office-Dr. Liu Xiuyun 9:30 pm end of activity
About The University of Maryland Medical Center: The University of Maryland Medical Center is an 800-bed teaching hospital in Baltimore and the flagship institution of the medical system of the 12th Hospital in Maryland. As a national and regional referral center for trauma, cancer care, neurological care, heart care, women ’s and children ’s health and physical rehabilitation, UMMC will provide treatment for patients referred nationally and regionally for time-sensitive intensive care medicine . UMMC is also one of the largest solid organ transplant programs in the United States, with several abdominal and chest transplants performed each year. All working doctors at the Medical Center are teaching doctors at the University of Maryland School of Medicine.

2020 Hopkins Salon IV: Regulate mental health in an outbreak
2020-04-03 00:00 (America/New_York)
2020 Hopkins Salon IV: Regulate mental health in an outbreak
Description: This event is in cooperation with the Cleveland Medical Center, please contact CCF-CSSA for details; thank you for your attention!

2020 Hopkins Salon / New Crown Virus (COVID-19) Webinar Part 4
#Regulation of mental health under epidemic situation #
Speaker: Xiao Jinsong Professor of Central South Hospital of Wuhan University
Time: April 3rd (Friday) Eastern Time 8:00 pm-9pm
Beijing, China April 4th (Saturday) 8: 00-99: 00
Participation method: Zoom online lecture, click zoom (https://zoom.us/join)
Enter the Zoom ID: 939-781-101
The new coronavirus (COVID-19) is spreading globally in 2019, and has been declared a public health emergency by the World Health Organization. The recent epidemic situation in the United States has increased. According to the New York Times, this week (March 28), the number of people infected with the new coronavirus has exceeded 100,000, and more than 1,500 people have died. In order to control the epidemic, there are currently 24 states in the United States that have imposed a “stay at home” ban, which has affected at least 223 million people across the United States.
The spread of the epidemic has caused more or less changes in our study, work, and lifestyle. Faced with these sudden changes and uncertainty about the future development of the epidemic, have you ever felt emotions such as fear, anxiety, boredom, loneliness, anger, etc.? Are these emotions normal? How to adjust?
In this issue, the Hopkins Salon and CCFCSSA focused on the mental health of people under the epidemic. In particular, Professor Xiao Jinsong of Central South Hospital of Wuhan University was invited to bring you an issue about “Psychological problems and adjustment during the COVID-19 epidemic” Lecture.
The report includes:

The psychological impact of the epidemic on international students;
Popular psychological symptoms;
Consultation case;
Self-regulating method.

Contact person:
Cleveland-Huang Pengjing (WeChat: pengjing038147)
John Hopkins-Liu Xiuyun (WeChat: 353568859)

2020 Hopkins salon III: a clinical analysis of the U.S. epidemic
2020-03-21 00:00 (America/New_York)
2020 Hopkins saloon/novel coronavirus (COVID – 19) webinar iii
#Analysis of the outbreak in the United States#
Speaker: wei cui, clinician, Johns Hopkins Suburban hospital
Saturday, March 21 at 8 p.m. Et
Online activities, non-members can also participate
Background: how exactly is the United States immune?
Johns Hopkins Suburban hospital is located in Bethesda, Montgomery county, Maryland, United States capital region. Since its establishment in 1943, it has provided medical services to the county and surrounding areas, affiliated with many local health care organizations, including the national institutes of health (NIH). Specialized in surgery, orthopedics, cardiology, neurology, oncology, emergency/trauma, and a variety of other clinical services, the hospital is the designated trauma center in Montgomery county.
Novel coronavirus (COVID – 19) is spreading globally and has been declared a public health emergency by the world health organization. Last week, the White House declared a national emergency. Hopkins hospital has also confirmed the infection among health care workers.
This issue of Hopkins salon focuses on the epidemic prevention situation in the United States, especially invites Cui Wei, a clinician from Suburban hospital of Johns Hopkins medical system, to analyze the epidemic situation in the United States and share the first-line clinical experience. 2) first-line experience in epidemic prevention; 3) how individuals respond to new outbreaks.
Hopkins salon 2020 issue iii
• Topic: analyzing the epidemic in the United States: health care systems, clinical experience, and personal protection
• Speaker: wei cui | Johns Hopkins Suburban hospital
• Time: March 21, 8-9 p.m. Et Saturday
• Where: live online
Sign up: free
Registration: click 【Read the original】
Guest:
Dr. Wei cui/clinician
Johns Hopkins medical system/Suburban hospital
JAMA internal medicine clinician and attending physician at Johns Hopkins Suburban hospital. Graduated from west China medical university with a master’s degree in urology. He received training in surgery, anesthesia and analgesia, and medicine at the Albert Einstein college of medicine, the university of California, San Francisco (UCSF), and the Johns Hopkins university hospital of medicine. He is a physician certified by the American medical association and elected a FACP fellow of the American academy of internal medicine for his outstanding medical ethics and skill. In 2016, Dr. Cui wei won the title of “outstanding Chinese in the greater Washington area”.
Host:
Dr. Chen fenghao/AI healthcare
LINKSciences/CEO, Hopkins innovation and entrepreneurship club
Dr. John Hopkins university, former director of research for the Americas at BGI and founder of LINKSciences, a medical artificial intelligence company. LINKMedicine (le fine medicine) subdivision disease specialty analysis platform, with leading algorithm and independent intellectual property rights, covering 5,000 hospitals in the United States, more than 70,000 subdivision disease, from the hundreds of millions of plans to find the best way to ask for treatment, is a new generation of data-driven hospital evaluation gold standard. President and head of innovation center of Hope Huafeng| Hopkins innovation and entrepreneurship club.
Active process
7:45-8:00 PM online check-in, guests exchange
8:00-8:45pm keynote: the current outbreak in the United States
8:45-9:00pm audience questions and answers /Q&A
The event ends at 9:00 PM

2020 Hopkins Salon II: Big data AI technology responds to the crisis of new coronavirus
2020-03-07 00:00 (America/New_York)
Speaker:
Dong Ensheng / Developer of the Epidemic Map of the United States Center for Systems Science and Engineering (CSSE) of Johns Hopkins University.
Date And Time Sat, March 7, 2020 7:45 PM – 9:30 PM EST
Online activities, non-members can also participate

Since the outbreak of endemic “unexplained pneumonia” discovered in Wuhan, Hubei Province, China in late December 2019, it has spread to every province and more than 40 countries in China. As of February 28, more than 100 cases have been diagnosed 85,000. Outside China (such as South Korea, Italy and Iran) has become more serious. Even CDC officials have warned of a coronavirus outbreak in the United States. In response to this ongoing public health emergency, the Johns Hopkins University System Science and Engineering Center (CSSE) has developed an online interactive dashboard to visualize and track reported conditions. This tool is the first epidemiological monitoring tool for COVID-19 epidemiology and has become the most popular visualization tool in the world. It can be used to track global and local COVID-19. The results of this project were published in the recent Lancet on.
As of the end of February, users from almost every country in the world have used more than 5 million times. It has also been reported in the “New York Times”, CNN, “Washington Post”, “Fox News” and other mainstream media in the United States and the world. In this issue of the Hopkins salon, focusing on the application of big data and artificial intelligence technology and public health, the development team of the epidemic map is specially invited to share the key technologies needed to build this tool and some interesting background stories. For example, how it was first created, how to maintain data, how to develop, who are our users, and their usage. We are also fortunate to invite the head of the “New Coronavirus Pneumonia Outbreak Distribution” project leader of the China National Center for Disease Control and the first-line clinicians in the United States and AI medical experts to participate in the discussion to discuss the application of new technologies in the most advanced disease prevention and clinical control.
-Speakers- Dong Ensheng / Developer of the Epidemic Map of the United States Center for Systems Science and Engineering (CSSE) of Johns Hopkins University. PhD student of Johns Hopkins University, Department of Civil and Systems Engineering / Systems Science and Engineering Center (CSSE) / JHU Bloomberg Infectious Disease Dynamics (IDD) group of the School of Public Health. Research areas involve network science, mobility modeling, machine learning, spatial analysis, data visualization, and infectious diseases. His recent work includes predicting measles risk in the United States and Pacific Island Countries and Regions (PICT), visualizing and modeling new coronavirus (COVID-19), and predicting dengue outbreaks in Sri Lanka.
-group discussion- Dr. Limin Yu / Clinician of Pathology, Director of Pathology Informatics, former Chairman of the Information Committee of the American Academy of Dermatology and Pathology, an expert in medical big data and artificial intelligence. American certified pathologist and dermatologist. Currently, William Bauman Medical
System, Michigan, USA is a skin pathologist and director of pathology informatics. He was the chairman of the Information Committee of the American Academy of Dermatology and Pathology. He serves as the director and member committee of the North American Chinese Dermatology Association, the chairman of the North American Chinese Pathologist Association’s Dermatology, Education Committee, and the pathology branch. In addition to clinical medicine, he also has a master’s degree in computer and more than ten years of software development experience. Engaged in a number of molecular biology and bioinformatics research and development, and won a number of scientific research and innovation funds, including the National Best Bioinformatics Award. The current research direction is medical big data and artificial intelligence. It is one of the few American clinicians with deep computer background. Dong Xiaofei, Manager of Platform Implementation Department, Beijing Branch of Yizhirui (China) Information Technology Co., Ltd. Responsible for the consultation and implementation of geographic information platform projects in Beijing Branch. After the outbreak of the new coronavirus pneumonia, it is responsible for the consultation and implementation of the application project of the “New Coronavirus Pneumonia Epidemic Distribution” application by the Chinese Center for Disease Control and Prevention (CDC).

2020 Hopkins Salon I: Respiratory expert to share insights into 2019-nCov: the outbreak, current status, and future perspective
2020-02-06 00:00 (America/New_York)
About this Event

Agenda:

2:45pm, Registration and Network
3-3:45pm, Speech by Dr Vij
3:45-4pm, Q&A

Be noted:

Please enter from Remington Ave entrance
Look for Fast Forward University (FFU)/Johns Hopkins Sign
Paid or street parking available on 29th or Remington Ave

Speaker Profile:
Dr. Neeraj Vij is a President & CEO of PRECISION THERANOSTICS & VIJ BIOTECH. He is a prominent scientist with expertise in respiratory medicine, and drug and medical device development. Dr. Vij’s laboratory over the years have been involved in development of novel prognosis-based intervention strategies, leading to the foundation of PTNx for bench to bedside translation for serving the needs of patients suffering from chronic or fatal conditions.
Dr. Vij received his PhD in Biotechnology from Indian Institute of Technology in 2001, and was also a recipient of international fellowship at Institute of Genetics, Biological Research Center (Centre of Excellence of the European Union), Hungary in same year. He subsequently completed his postdoctoral research at University of Heidelberg, Germany and Johns Hopkins University School of Medicine. He was Assistant Professor at the Department of Pediatrics, Pulmonary Medicine and Institutes of NanoBiotechnology and Global Health, JHU before moving to CMU to help establish a new medical school as an Associate Professor. He continues to serve as Adjunct Faculty at Johns Hopkins University School of Medicine.
Dr. Vij serves on the Editorial Boards of several high impact journals and has been invited to help organize several conferences and seminars. He is also frequently invited to serve as a reviewer for various Journals and grant review study sections. He is a Life Member of American Society for Nano Medicine (ASNM) and several other international scientific societies. He is a recipient of several research awards, grants (NIH and foundation) and recognition for his scientific contributions. He has also been involved in training and education of students and research/clinical fellows in various capacities leading to placements at top-tier universities, medical schools or industries.

2020 Webinar I: President of Johns Hopkins invites you to participate in: New Coronavirus (2019-nCoV)
2020-02-05 00:00 (America/New_York)
New Coronavirus (2019-nCoV) Webinar
Wednesday, February 5, 2020
11:30 a.m. EDT
Click the URL: https://video.ibm.com/channel/johnshopkinsu
Follow 【Hope Huafeng】
Follow up entrepreneurial innovation from Hopkins!
President Daniels writes to All Alumni
Dear alumni and friends,
The outbreak of the new coronavirus (2019-nCoV), which originated in Wuhan, Hubei Province, China, is spreading globally, and has now been declared a public health emergency by the World Health Organization and the US government, which has led to people’s doubts and the attention from our community. Clinicians and researchers at Johns Hopkins University, who specialize in global public health, infectious diseases, and emergency preparedness, have always been working on increasing awareness of the virus, notifying the public, and briefing decision makers to guide the response. They are at the forefront of the international response while caring and saving lives.
At 11:30 am on February 5 (Wednesday), a team of these experts will bring their knowledge directly to you. The Johns Hopkins Bloomberg School of Public Health will host a 30-minute webinar, which will invite some of the best talents to solve global health problems.
Guests and moderator:
Dr. Tom Inglesby:
Director, Center for Health Safety, School of Public Health
Professor of Environmental Hygiene and Engineering
Dr. Caitlin Rivers
Senior Scholar, Center for Health Safety, School of Public Health
Assistant Professor, Department of Environmental Health and Engineering
Lauren Sauer
John Hopkins Office of Emergency Preparedness and Response (CEPAR) Operations Director
Assistant Professor of Emergency Medicine, School of Medicine
Brian Simpson (Moderator)
MA, A & S ’97, MPH, BSPH ’13,
Editor-in-chief of Hopkins Bloomberg’s Public Health and Global Health
You can submit your question via alumni@jhu.edu before the webinar, or you can post it via the “Q & A” module on the right side of the live video player.
To participate in the webinar, please click the following link: https://video.ibm.com/channel/johnshopkinsu
I hope you will find this lecture helpful and it will encourage you to continue to look for information and any help you need, including health and wellness resources for students, faculty, and staff.
For more than 100 years from the pandemic to the outbreak of the Ebola epidemic, we have been facing international health challenges. Johns Hopkins is organizing its thinking and personnel to ensure the health and security of millions of people around the world. Thank you for your efforts during this time, whether you are directly involved in the immediate response or taking the time to stay informed.

Dr. Ronald J. Daniels
President of Johns Hopkins University
Protecting Health, Saving Lives
– Millions at a Time.
The Johns Hopkins Bloomberg School of Public Health has a big vision
About us
The Hopkins Innovation and Entrepreneurship Club
HIEC is a global non-profit organization established in 2012 in Maryland, USA, relying on the campuses and alumni groups of Johns Hopkins University to create an international innovation ecosystem and promote high-tech, biomedical, and medical scientific research, investment, and entrepreneurship.

Contact us
info@hopkinsclub.org

2018 Hopkins Venture Forum
2018-04-21 | Johns Hopkins University, 3400 North Charles Street, Baltimore, 21218, United States
The 2nd Hopkins Venture Forum / Featured in 2018 Johns Hopkins China – U.S. Summit
Request for application – Pitching Your Startup Roadshow
Winner receives $1,000 Prize

April 21, 2018
Johns Hopkins University Homewood Campus

Organizers
Johns Hopkins China – U.S. Summit Association
The Hopkins Club for Innovation and Entrepreneurship
The Johns Hopkins Chinese Students and Scholars Association
Pan Asia Career Development Alliance
Johns Hopkins PEVC Club
Johns Hopkins Financial Technology Group
Blue Net China at Johns Hopkins

Invitation
The Johns Hopkins China-US Summit – The Hopkins Venture Forum 2018 will be held in Baltimore, Maryland on April 21, 2018! The forum is co-sponsored by the Johns Hopkins China – U.S. Summit Association, the Johns Hopkins Chinese Student and Scholars Association (JHU-CSSA), and the Hopkins Innovation and Entrepreneurship Club (The Hopkins Club). It is also supported by the Pan Asia Career Development Alliance (PACA), Johns Hopkins PEVC Club, Johns Hopkins Financial Technology Group, and Blue Net China at Johns Hopkins.
As a boutique module of the Johns Hopkins China Summit, the venture forum will bring together technological innovation and bio-health leaders, founders of emerging and growing companies, and investment professionals. The forum includes industry leaders’ speeches, startup roadshows, and venture capital deal matching. The forum focuses on current innovation breakthroughs in biotechnology, medical instruments, scientific research tools, digital health, population health informatics, big data artificial intelligence and other fields.
The core roadshow teams of the forum cover a number of healthcare ventures from the Johns Hopkins University, and the Greater Washington area. The Hopkins Club will have training sessions for all selected projects to enhance their pitching skills. Our social media will also cover roadshows events during the summit and recommend startups to potential investors.
The first winning team will receive $1,000 prize.
Application
Prepare the following document:
Pitch Deck
Company Logo
Business Plan
Application deadline 1st April 2018:
Register you project at: http://hopkinsclub.org/project-portal/
Email supplement document: info@hopkinsclub.org
Receive training session schedule from The Hopkins Club, if project get selected

More Questions
Contact us at info@hopkinsclub.org

Interpretation of New Immigration Policy and Approaches to Current US Immigration (EB1 & EB-6)/2018 Hopkins Salon Series III
2018-03-25 14:00 - 16:00 (America/New_York) | Hodson Hall 210, 3400 N. Charles St. Baltimore MD 21218, Hodson Hall 210, 3400 N. Charles St. , Baltimore, United States
你还在为怎样顺利拿到工作签证H-1B感到一筹莫展么？难道H1-B是唯一选择么？作为高学历高智商的你，如何才能快速又准确的搞定移民身份问题？作为有博士学位的你为什么现在是特殊人才最佳办理时期？特殊人才和创业签证到底如何办理？

3月25日下午，霍普金斯创新创业俱乐部，携手霍普金斯大学中国学生学者联合会(CSSA)，邀请到美国律师协会连续两届德州十佳移民律师唯一的华裔律师：田方中律师，为你带来特殊人才及创业签证的独家解读。不见不散！

speaker简介：田方中律师拥有美国法学博士学位、英美文学本科和硕士学位及电脑方面硕士学位，曾任大学英语教师和华为公司第一任海外市场部经理。
除了美国德州的律师执照外，田律师还拥有联邦地区法庭德州东部庭的执照和联邦第二巡回法庭的执照。目前，田律师是美国联邦律师协会会员和德州律师协会会员。田律师还于2017年和2018年连续两年获得德州十佳移民律师的荣誉。
田律师成功办理特殊人才、庇护，婚姻和家庭团聚绿卡的申请，他拥有极为丰富的全美各地上庭经验，同时精通于撰写各类上诉状，上诉成功率非常高。

2018霍普金斯创业沙龙IV：高端生物医药-中国的创新创业难点
2018-03-24 12:00 - 15:00 (America/New_York) | Harbor Launch, 701 E Pratt St,, Baltimore, MD, 21202, United States
主讲嘉宾：
汤斌博士
山西千人计划特聘专家、美国奥美佳生物科技公司高级顾问
山东菱花集团循环经济研究院名誉院长
时间：2018 年3 月24 日，星期六下午12:00-15:00
地点：LINKSciences @ Harbor Launch
地址：701 E Pratt St, Baltimore, MD 21202

演讲内容：
创新难、创业更难。创新往往是不同领域交叉碰撞出来的火花；创业要复杂的多、它包括与时俱进的技术产品和服务、沉重的经济效益和资本运作压力、敢于担当的责任和义务、事无巨细的管理和运作。特别是目前高端生物医药行业、由于分子生物学各领域的突飞猛进，给我们人类医学带来了前所未有突破性进展。细胞治疗已经成为继传统手术和药物治疗之后最伟大的医学治疗转折点！
主讲人汤斌博士将围绕这一点、跟大家探讨生物医药领域在中国创业创新方面的问题和难点。同时汤斌博士还将物色几位做完博士后的医学专家作为青年千人计划专家和复旦大学副教授的候选人。

嘉宾简介：
科技部海外特聘专家、国家973计划评审专家、中国科协海外智力专家、旅美科技会前任会长、欧美同学会山东省常务理事（2018年首届）。现任美国奥美佳生物科技公司高级顾问、山东菱花集团循环经济研究院名誉院长，山东偌帝生物工程公司执行总裁。主要从事应用结构生物学技术理念、设计和基因工程改造多肽抗体和多种疫苗蛋白研究。
活动日程：
12:00-13:00
签到，Pizza 午餐，自由交谈
13:00-13:10
宣布创新论坛开始，介绍活动内容，介绍参会嘉宾
13:10-14:10
汤斌博士演讲及问答
14:10-14:30
关于青年千人计划专家和复旦大学副教授的候选人的问答
14:30-15:00
联合主办单位介绍，近期创业创新活动预告
首届约翰•霍普金斯中美峰会暨第二届霍普金斯创投论坛
4 月21 日 http://hopkinsclub.org/project-portal/
第13 届华盛顿创新创业与投资论坛暨美东创业大赛,区块链论坛及创业大赛
(4 月8 日）http://www.uctid.org/contest4/
15:00 活动结束，自由交谈

组织单位
联合主办：美中创新创业联盟，美国中美联合商会，霍普华丰|霍普金斯创新创业俱乐部
协办单位：美中技术创新与发展中心，美国华人教科文中心

Startup Academy
2018-03-11 13:45 - 16:15 (America/New_York) | Johns Hopkins University, 3400 North Charles Street, Baltimore, 21218, United States
As one of the new initiatives of The Hopkins Club for Innovation and Entrepreneurship (The Hopkins Club) for 2018, the Startup 101 course aims to provide a series of introductory classes to the new (or soon-to-be) entrepreneurs in the Hopkins and greater Baltimore communities.
Time: 1:45-4:15pm
Venue: 701 E Pratt St, Baltimore, MD 21202
Language: Chinese

The Startup 101 course curriculum is developed around 8 key building blocks that are essential to the success of startups. At the center, ‘Idea’, ‘Product/Service’, and ‘Commercialization’ form the core of every startup and they define what a business does and how it makes money. Surrounding the core building blocks, ‘People & Culture’, ‘Operations & Management’, ‘Finance & Fundraising’, and ‘Regulations & Administration’ are key supporting elements that directly impact the performance and sustainability of the business. Finally, ‘Tools and Resources’ refer to the affordable or free business tools, information, and services that can accelerate the growth of startups. These tools and resources can address and facilitate any of the other building blocks mentioned above.

On March 11th, The Hopkins Club will host the first Startup 101 Workshop with an introduction to the course curriculum and three classes. The classes will address the topics of ‘idea’, ‘product/service’, ‘commercialization’, ‘people & culture’, ‘finance & fundraising’, and ‘regulations & administration’. We look forward to your participation!
Note: the workshop will be conducted in Mandarin.
Agenda
1:45 – 2:00 pm Registration
2:00 – 2:10 pm Welcome and Opening by Dr. Fenghao Chen
2:10 – 2:30 pm Introduction to The Hopkins Club Startup 101 Program by Zheying Mao
2:30 – 3:00 pm A Brief Overview of Commercialization: from Idea to Business by Dr. Bo Bi
3:00 – 3:30 pm Setting the Stage for Investment: Legal Fundamentals for Startups by Dr. Peng Sun
3:30 – 4:00 pm Fundraising for Biotech Startups by Dr. Jiayi Zhang
4:00 – 4:15 pm Closing and Networking
Speakers
Dr. Bo Bi, Ph.D., Managing Director at InnoScouting
Dr. Peng Sun, J.D., Ph.D., Associate Patent Attorney at Foley & Lardner LLP
Dr. Jiayi Zhang, MBA, Ph.D., Manager at Paragon Bioservices, Co-founder of The Hopkins Club for Innovation and Entrepreneurship

2018约翰霍普金斯大学官方创业资源分享会
2018-02-21 17:30 - 19:00 (America/New_York) | Charles Commons Salon A/B, 3301 N Charles Street, Baltimore, MD, 21218, United States
2月21日下午，霍普金斯创新创业俱乐部，携手霍普金斯大学中国学生学者联合会(CSSA)，邀请David Greenwald, Director of Corporate Relations at JHTV, 为大家分享学校官方的创业资源，欢迎大家参加分享会。

2017 Annual Gathering of The Hopkins Club for Innovation and Entrepreneurship
2017-12-17 12:00 - 14:00 (America/New_York) | Johns Hopkins University, 3400 North Charles Street, Baltimore, 21218, United States
2017 Annual Gathering of The Hopkins Club for Innovation and Entrepreneurship
Time: 12-2pm
Date: Sunday, Dec 17, 2017
Venue: Hodson Hall, Johns Hopkins University Homewood Campus, 3400 N. Charles Street, Baltimore, MD 21218
Program:

Annual review of 2017 and showcase the plan for 2018;
Social & network with like-minded colleagues, team member, and friends;
Pizza and refreshment will be provided.

RSVP is required.

Workshop on writing business plans and performing due diligence | Start Up Saloon VII
2017-10-15 14:00 - 15:00 (America/New_York) | Johns Hopkins University, 3400 North Charles Street, Baltimore, 21218, United States
The Speaker: Liwei Liu MBA, Investor, CRCM Ventures

Time: 2-3 pm, Oct 15, 2017
Venue: Hodson , Johns Hopkins University, 3400 N. Charles St, Baltimore, MD 21218

Abstract:
Hopkins alumnus, Liwei Liu, currently an investment manager at CRCM (ChinaRock Capital Management), is coming to The Hopkins Club for Innovation and Entrepreneurship this Sunday to share with us the tips and tricks on business plan writing for entrepreneurs from an investor’s perspective. He will also touch upon the topic of conducting due diligence for both the entrepreneurs and the investors.
We welcome any entrepreneurs, investors, and other interested guests to join us on Sunday.
About CRCM:
Headquartered in San Francisco, CRCM manages $170mn of funds and invests in seed and early-stage companies in the United States and China. CRCM’s successful ventures include Youku (NYSE: YOKU), E-House (NYSE:EJ), Allyes (acquired by FMCN), Yingli (NYSE: YGE) and many others. Among those ventures, Sonavex and Vixiar are two medical startups based out of Baltimore and their investments were led by Liwei, our speaker for this workshop.

Startup Journey in the Eyes of Investors: An IDG Perspective | Start Up Saloon VI
2017-08-27 14:00 - 15:00 (America/New_York) | Johns Hopkins University, 3400 North Charles Street, Baltimore, 21218, United States
The Speaker:
Zixuan Pang, Ph.D.
Healthcare Associate, IDG Capital

Time: 2-3 pm, Aug 27, 2017
Venue: Hodson 305, Johns Hopkins University, 3400 N. Charles St, Baltimore, MD 21218

Abstract:
Dr. Zixuan Pang, an investment manager of IDG Capital will share his experience and perspectives from venture capital to invest in tech start-ups. Dr Pang received his BS degree in Biological Sciences from Peking University, and then obtained his Ph.D. degree In Biochemistry at the Johns Hopkins University School of Medicine. In 2015, he joined PreScouter, inc. as a technical consultant at Chicago. In 2017, he worked for IDG Capital as investment manager.

About IDG: IDG Capital is the first foreign Venture Capital investment institution, it was the early investor for companies including Tencent, Baidu, Ctrip, and 360, etc. During the company’s 24 years of history, IDG has invested more than 500 companies. This talk would be a great gateway to entrepreneurs who are looking for investment in this field.

Regional Resources for Technology and Innovation Development | The Hopkins Start Up Saloon V
2017-08-06 14:00 - 15:00 (America/New_York) | Johns Hopkins University, 3400 North Charles Street, Baltimore, 21218, United States
Nina Lamba Ph.D.
Senior Program Manager
BioMaryland Center, Maryland Department of Business and Economic Development, State of Maryland

Time: 2-3 pm, Aug 06, 2017
Venue: Hodson 316, Johns Hopkins University, 3400 N. Charles St, Baltimore, MD 21218

Biography:
Nina Lamba is Senior Program Manager of the BioMaryland Center within the Maryland Department of Business and Economic Development. One of the original members of Maryland Life Sciences Advisory Board. She has also made significant contributions to the biomedical literature, including 1 book, 4 book chapters, and 8 journal articles, and is a patent holder. She is a Member of the American Chemical Society and the Royal Society of Chemistry (UK).
Dr. Lamba holds a B.Sc. (Honors) degree in Applied Chemistry from Aston University, U.K. and a PhD degree in Bioengineering from the University of Strathclyde, U.K. She joined the Department of Chemical Engineering at the University of Delaware as a post-doctoral research fellow. After, she was Director of Biomedical Technology for a small technology company. In 2003, she co-founded CCL Biomedical, Inc., a small company spinning out of University of Delaware, focused on developing antimicrobial compounds, and developing textiles for infection control and biodefense. She led the company through technology development, product optimization, and pre-pilot assessments.

SAPA-Hopkins Venture Forum @ US-China Biopharma Congress
2017-06-24 09:30 - 15:30 (America/New_York) | Sheraton Valley Forge Hotel , 480 N Gulph Rd, King of Prussia, PA , 19406, United States
SAPA-Hopkins Venture Forum is a joint event proudly organized by Sino-American Pharmaceutical Professional Association (SAPA-GP) and The Hopkins Club for Innovation and Entrepreneurship (The Hopkins Club). The forum brings together industry leaders, emerging fast-growth companies, innovative technology creators, and members of the investment community with a focus in biohealth innovation.
TIME & VENUE:

Time: 06/24
Venue: Sheraton Valley Forge Hotel, King of Prussia

PROGRAMS: (TBA)

Keynote Speech: Delivered by industry leaders and inspirational speakers
Roadshow: “To raise capital you need a startup roadshow”
“Magic”Match-Making: In-depth meetings between appealing projects and VC

WHO SHOULD COME?

Startups who are looking for investment
Individual Investors
Government Investors
Venture Capitals Firms
Incubator Management Operator
Potential Entrepreneurs

About the Organizers:
Sino-American Pharmaceutical Professionals Association – Greater Philadelphia (SAPA-GP) is a professional non-profit organization founded in 2002, which strives to serve the rapidly growing pharmaceutical professional community in the Greater Philadelphia area. Over past decades, SAPA-GP has established a broad member base range from global pharmaceutical companies (e.g. BMS, GSK, Johnson & Johnson, Merck, Pfizer, Teva) to biotech companies (e.g. Alliance Pharma, Frontage Laboratories, PuraCap, Shire) and local academic institutions. SAPA-GP has become the premier organization in the region for bridging the pharmaceutical and healthcare industries of China and the US.

The Hopkins Club for Innovation and Entrepreneurship (The Hopkins Club), founded in 2012, was originally a student group serving Chinese start-up projects. Over the years, The Hopkins Club has been evolving into a gateway to innovation within and beyond Hopkins community. Now Hopkins Club serves as a professional non-profit organization that dedicates to the fostering of innovation and entrepreneurship ecosystem at local and regional. At present, the Hopkins Club have more than 10 individual investors and VC firms as well as 6 Entrepreneurship Park on board.

About the Venue:
Sheraton Valley Forge Hotel is ideally situated for both business and leisure travelers. It is easily accessible from both the Schuylkill Expressway and the Pennsylvania Turnpike and are located just a 20 minute drive from city center Philadelphia and 30 minutes from Philadelphia International Airport. Shoppers will delight in our proximity to the King of Prussia mall, located just a around the corner from the hotel, and Philadelphia Premium Outlets, which are only a 15 minute drive away. Nearby Valley Forge Historic National Park is a great destination for history buffs and nature enthusiasts alike.

霍普金斯创业沙龙-4：FROM BENCH TO ASSETS: BUILDING A VALUABLE PATENT PORTFOLIO.
2017-06-11 13:00 - 14:00 (America/New_York) | Johns Hopkins University, 3400 North Charles Street, Baltimore, 21218, United States
FROM BENCH TO ASSETS: BUILDING A VALUABLE PATENT PORTFOLIO.
主讲：孙芃律师
时间：6月11日（本周日）
地点：约翰·霍普金斯Homewood校区（具体地址TBA）
注册：俱乐部网站（TBA）

【嘉宾简介】
孙芃律师在乔治敦大学法学院（Georgetown University Law Center）获得法学博士，并在马里兰大学医学院获得生物医学博士 ，现工作于富力达律师所（Foley & Lardner， LLP）驻华盛顿办公室。孙芃律师长年对各类生命科学机构（学校，研究机构， 制药厂以及生物公司）进行专利法方面的法律咨询，尤其是帮助生命科学机构通过专利法来对生命医药创新来保护, 维护，以 及增值，同时参与帮助客户完成并购(M&A)和企业上市(IPO)的尽职报告。在加入富力达律师所之前，孙芃律师致力于帮助客 户解决关于FDA法律的事务，尤其是FDA管辖产品在美国销售，商业宣传，以及监管过程。孙芃律师曾在美国联邦索赔法院（ U.S. Court of Federal Claims) 为 Susan Braden 和 Dania Zane做法院实习。

霍普金斯创业沙龙-3：INNOVATIVE ENTREPRENEURSHIP MODEL IN CHINA
2017-04-02 14:00 - 15:00 (America/New_York) | Hopkins Club, 701 E Pratt St, Baltimore, MD, 21202, United States
INNOVATIVE ENTREPRENEURSHIP MODEL IN CHINA
Speaker：David Dai, Ph.D.
Scientific Director/Janssen Fellow in Drug Product Development at J&J, AAPS Fellow
Johns Hopkins Alumni ’96

More about the Speaker:
戴卫国博士简介
美国全球强生制药集团公司药物产品开发部科学总监，美中医药开发协会(SAPA)2015-2016 总会主席。
2013年，当选为美国药学家学会Fellow (AAPS Fellow)。2012年当选为美国强生制药集团公司全球首届62名JANSSEN FELLOW之一。JANSSEN FELLOW是强生制药集团公司授予该公司内国际上公认的顶级科学家的最高科学荣誉，以表彰他们对科学做出的重大贡献和公司的影响。
荣获了多项声誉奖项，包括2011年度强生制药集团公司Philip B. Hofmann杰出研究科学家奖 (美国强生集团公司最具盛名的研发奖项之一)。担任过美国药学家学会（AAPS）工业药学与生物药剂学部 (PPB Section) 主席等领导职务。现任美国药学家学会 AAPS Fellow评审委员会11名评委名之一,工业化生产制造及科学学部(MSE) Fellow 评委会主席, 10家英文医药期刊的编辑或编辑顾问委员会成员,现为美国2个大学药学院的兼职教授。作为杰出华人专家代表,多次受到党和国家领导人习近平总书记,李克强总理, 张徳江,张高丽等接见。
戴卫国博士研究和创新成就主要集中在开发小分子新药及生物大分子抗体/多肽产品,药物的新配方筛选, 颠覆性药物传递技术, 新型制剂及剂型(含长效/缓释技术), 生物大分子药物产品的生产工艺开发，放大，工业化生产，抗体药物的递送器械,器具与预填充注射器。他的技术创新除已直接成功地多种药品上市, 同时也吸引数十亿美金的资金用于建立相关的研究开发项目。除了工业研发，产业化成就外，戴愽士在专家评审的生物医药专业杂志上发表了50篇研究论文。受邀在许多国际学术会议和研讨会上作大会发言, 并担任各类国际学术会议和研讨会主席三十余次及多项国际性学术团体/专业性协会 (AAPS, CRS)评奖委员会委员。
戴卫国博士于1996年获得美国约翰霍普金斯大学博士学位，曾在多家生物/制药公司包括在美国强生制药集团公司药物产品开发部和美国安进 (Amgen) 公司制药部从事及领导新药产品开发, 已拥有二十年美国工业界新药研发领导工作经验。

About the Organizer :

The Hopkins Club for Innovation and Entrepreneurship is dedicated to the advancement of entrepreneurship, promotion of innovation, and the ideals of leadership and learning. We are a Hopkins alumni-led 501(c)3 non-profit organization to foster innovation and entrepreneurship ecosystem at local, regional, national and global level. We are proud to connect Hopkins alumni from all schools globally and empower Hopkins Alumni Startups. We are dedicated to bring together the spirit of innovation and entrepreneurship within and beyond the Hopkins community.

For Entrepreneurs: We bring the unsung heroes together for future greatness. JOIN US NOW!
For Investors: A gateway to access innovation from Hopkins community, Baltimore/Washington metropolitan, and beyond! View start-up projects!
To Team Up? A unparalleled venue to find brightest minds alike; your future CXO is just among our members! Find your teammates!

Please join us if you are scientific innovators, entrepreneurs, professors, business professionals, or anyone interested in innovation and entrepreneurship.

霍普金斯创业沙龙-2：Innovation Commercialization and A Fit Plan
2017-03-19 14:00 - 16:00 UTC | Hopkins Club, 701 E Pratt St, Baltimore, MD, 21202, United States
霍普金斯创业沙龙系列：
『讲述创业者自己的故事，尽在霍普金斯创业英雄汇』

INNOVATION COMMERCIALIZATION AND A FIT PLAN
Speaker： Charles Li, MBA,
Senior Director of Business Development, Poochon Scientific LLC

Topic:
To start a new business, you shall take at least three months’ hard work to project at least two years down the road. If you don’t get it right, you may worked yourself away from your dream. In his talk, Charles will illustrate an effective method adopted by NSF and NIH on how to validate customers for a product/service with examples he had collected from his life.
About the Speaker:
Charles Li is a self-motivated business developer in pharmaceutical and biotechnology sector with proven track record, supreme team-building skill and fun-to-work-with personality. Charles is a former research scientist with fifteen years of experience in pharmaceutical research and development, his scientific expertise includes medicinal chemistry in cancer and neurodegenerative disease, molecular imaging probe development for biomedical research and clinical diagnosis.
Agenda
-Charles Li will present the topic “Innovation commercialization and a fit plan”
-Discussion about the Hopkins Club 2017 Programs
-Launch membership programs and volunteer programs
-Network event

About the Organizer :

The Hopkins Club for Innovation and Entrepreneurship is dedicated to the advancement of entrepreneurship, promotion of innovation, and the ideals of leadership and learning. We are a Hopkins alumni-led 501(c)3 non-profit organization to foster innovation and entrepreneurship ecosystem at local, regional, national and global level. We are proud to connect Hopkins alumni from all schools globally and empower Hopkins Alumni Startups. We are dedicated to bring together the spirit of innovation and entrepreneurship within and beyond the Hopkins community.

For Entrepreneurs: We bring the unsung heroes together for future greatness. JOIN US NOW!
For Investors: A gateway to access innovation from Hopkins community, Baltimore/Washington metropolitan, and beyond! View start-up projects!
To Team Up? A unparalleled venue to find brightest minds alike; your future CXO is just among our members! Find your teammates!

Please join us if you are scientific innovators, entrepreneurs, professors, business professionals, or anyone interested in innovation and entrepreneurship.
